Large incisions have been used by surgeons for generations to perform surgery, introduce the required surgical equipment, and get a complete view of the organ they needed to treat. The new era of robotic surgery has come into the limelight in the last two decades. To get a report in detail, contact us at - info@insights10.com
2. 2
Robotics in Surgery
The robotic surgery market is going to reach $12 Billion by 2030, growing at a CAGR of 19.3% during the
forecasted period 2022-2030
Key Insights:
• Robotic or automated surgery, allows doctors to perform numerous types of complex procedures with more precision,
adaptability and control than is possible with traditional techniques. Mechanical surgery is usually associated with negligibly
invasive surgery — procedures performed through small incisions
• Since certain operations, such radical prostatectomy and partial nephrectomy, lend themselves to the complexities of robotic
technology, urology has historically been the primary driver of robotics in the UK
• These procedures have become highly efficient with excellent outcomes, so future gains from improving surgical robotics are
likely to be had outside of this field in areas such as ear, nose and throat (ENT) and thoracic surgery alongside gynecology and
general surgery
• Improvements in commercial viability and accessibility will encourage the translation of the present robotic surgical systems into
a considerably larger range of procedures. Robotic utilization in these areas is currently growing quickly
• Manufacturers and software developers are using 3D imaging to create Augmented Reality (AR) solutions that can optimize
surgical procedures and training tools
3. 3
Robotics in Surgery: The Journey from Past to Present
1970
1975
1980
1985
1990
1995
2000
2005
2010
2015
2020
1970
NASA
explores
telesurgery
1983
First robot in
surgical
suite, used
to move
patient’s
limb into
position
during
orthopedic
surgery
1985
First robotic
surgery
performed.
PUMA 560
was used to
obtain brain
biopsy
1988
Transurethra
l resection
performed
by PROBOT
1992
ROBODOC
performed total
hip
arthroplasty.
Gets FDA
approval
1997
First
laparoscopy
performed
using a
robotic
system
2000
Da Vinci – the
first robotic
system for
general &
laparoscopic
surgery
2001
Da Vinci gets
FDA approval.
Used in
radiation
therapy,
Cyberknife
does
procedures
autonomously
2007
Sensei and
SpineAssist
receive FDA
approval for
intravascular &
spinal
procedures
2012-13
23,000hip &
knee
procedures
conducted
with MAKO
globally &
over 500,000
surgeries
performed
with Da Vinci
2019
Over 5,000 Da
Vinci surgical
systems
installed
globally & 6
million
surgeries
4. 4
Robotics in Surgery: Future Trends
Novel Surgical Platforms:
Novel surgical platforms and technology ownership models will continue to be introduced. New healthcare technologies
are often developed and introduced in response to tight hospital budgets. The infusion and widespread adoption of new
medical solutions are dependent on the availability of reasonably priced enabling technologies and new business models
Surgical Robots in ASCs:
Robotics-assisted technology can support the high volume, low-cost procedures that are typically performed with
ambulatory surgery centers (ASCs). Robotics-assisted technology offers low operating cost through the use of standard
reusable instruments and open-platform architecture that allows hospitals to leverage existing technology investments
Telehealth/Telesurgery:
The future of telesurgery relies on two factors – the availability of 5G and the widespread adoption of robotics-assisted
technologies. As 5G becomes more prevalent, coupled with advances robotics-assisted technologies, telesurgery will
become an increasing viable option for certain procedures
5. 5
• Versius consists of separate single arm
carts and an open console; wristed
instrument tips also provide seven
degrees of freedom
• Arms of Versius are lightweight and
provide ease of transport and
deployment
• Versatility of Versius, with the ability to
add and remove arm carts, makes it a
more practical portable solution
• Already been installed in hospitals in
Germany, Australia and the UK as of
June 2021
Novel Surgical Platforms
• Recently announced its surgical robot
platform, Ottava
• will consist of six robotic arms
integrated into the operating table;
design provides a zero footprint device
that frees up space and enables better
patient access
• J&J are also expanding into
orthopaedics with VELYS, their
table-mounted robotic system aimed at
increasing accuracy of bony cuts,
recently receiving FDA approval
• Recently performed the first patient
procedure, a radical prostatectomy,
using their contribution
• Hugo robotic-assisted surgery system
possesses similar qualities to CMR's
Versius, with its modular, open-console
design
• Compatibility with the globally-trusted
Medtronic surgical instrumentation may
make Hugo a more accessible and
successful competitor
CMR Surgical - Versius Medtronic - Hugo
Johnson & Johnson - Ottava
7. Who should buy this report?
MedTech
Players
HealthTech
Companies
Digital Health
Entities
Pharmaceutical
Players
Other Lifesciences
Companies
8. Cost of this report:
$2,500
Annual Subscription:
$125,000 $60,000
(Includes a total of 50 reports)
www.insights10.com
Will the Expiry of Humira Market Exclusivity and Entry of its
Biosimilars Move the Needle in BioPharma Market?
From the Fringes to the Forefront: mRNA is here to Transform
Global Health
Melting the Iron Triangle: 10 Healthcare Players aiming Beyond
Health Equality to Conquer Health Equity
Robotics: Embarking a New Era in Surgical Innovations
Metaverse: Paving the way for Health 4.0
Topics of Upcoming Reports
Healthcare Future Outlook 2023
Patient Engagement- a New Standpoint on Care that is
Patient-Centered
E-Rx, the Digital Version of Prescription Improvising the Chances
of Better Patient Outcomes
Integration of Healthcare Systems with Big Data and Data Silos
10. 10
Research Methodology
▪ Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the key growth drivers,
opportunities, and restraints that might promote or hinder the future industry growth along with an expansive overview of the competitive landscape to help our
clients make informed strategic decisions
▪ We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial phase of our study
where we conduct extensive data mining, referring to verified data sources such as independent studies, government and regulatory published material,
technical journals, trade magazines, and paid data sources
▪ For forecasting, the following parameters are considered:
❑ Market drivers and restraints along with their current and expected impacts
❑ Technological scenario and expected developments
❑ End use industry trends and dynamics
❑ Trends in the consumer behavior
❑ Regulatory scenario and expected developments
❑ Current capacity and expected capacity additions up to 2030
▪ We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected market growth rate
▪ We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-sensitive, reflecting the
most recent value and volume of the market across regions
▪ All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪ Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)
11. 11
Analysis Methodology
Our Analysis Methodology involves three critical stages:
01
02
01
02
03
01
02
03
Primary
Research
Secondary
Research
Market Trends
Market Sizing &
Analysis
Data Triangulation &
Validation
Analysis &
Interpretation
Insights
Presentation &
Reporting
Data Collection Market Data Analysis
& Statistical Model
Interpretation &
Presentation
12. 12
Data Triangulation & Data Validation
Bottom Up Approach
B
o
t
t
o
m
U
p
A
p
p
r
o
a
c
h
Summarization of revenue
generated from companies
to arrive at total market size
Revenue generated by products &
services offered by companies
Validation from
Primary Interview
Final
Market
Size
Top Down Approach
T
o
p
D
o
w
n
A
p
p
r
o
a
c
h
Final Market size break up to
rest of segmentation
Arriving at market size
of each segment
Validation from
Primary Interview
Final
Summary
13. 13
Key Benefits for Stakeholders from this Report
Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent
investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2021 to 2030F is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors
14. 2021
2022-
2030
Report Attribute
Quantitative Units
Report Coverage
Customized Report
Pricing and purchase
options
Revenue in USD Million/Billion (Mn/Bn)
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (5 working days) with
purchase. We will provide you with data that is
currently not a part of our scope as a part of
customization
Avail customized purchase options to meet
your exact research needs
Details
Time Frame
Base Year for
Estimation
Forecast
Period
15. The report is prepared
using a proven
methodology and
insightful research
Reliable
The data is prepared by
a team of highly qualified
& experienced research
analysts & vetted by our
local associates
Expert-verified
Allowing you to
confidently make
smarter business
and strategic
decisions
Real
Covers everything you
would need to know
about the market
including market size,
competitive analysis &
much more
Comprehensive
You do not have to be a
market expert to
understand what really is
happening on the market
and how it works
Easy to read
What kind of Data is Presented
in this Report?
This report presents data, which is:
www.insights10.com
17. www.insights10.com
A large database of over 30,000 syndicated market
research reports in pharmaceuticals and healthcare
sector at global, regional as well as country level. We
also provide customized research reports tailor made
to suit your needs
Lifesciences Market
Research Reports you
can trust
18. Insights10 is a healthcare focused market research
firm founded with an aim of being an insights driven
company in the data driven world and delivering
actionable insights that can drive decision and
strategy making process for businesses
Get Insights to take
informed Business
Decisions
www.insights10.com
19. Market Research Reports
across various domains of healthcare
Healthcare
Services
Clinical
Trials
OTC &
Nutraceuticals
Pharmaceuticals
(Diseases & Drugs)
Digital
Health
Medical
Devices
21. Our Research Process
01 03
02 04 05
Identification of
Data
Collection of
Data
Market
Dynamics
Collaboration
of Data
Verification &
Analysis
www.insights10.com
22. Statistical Databases
Data
Sources
We have access to multiple highly
reliable free and subscription data
sources. We have many years of
experience to understand which
sources are more dependable for what
and which to prefer for the reliable and
latest information.
Company Websites/Annual Reports
Trade Publications
Online Databases
Published Research Reports
Whitepapers
Press Releases of Key Market Players
www.insights10.com
23. Research Projects Done
Over the years, we have developed an in-depth experience of executing
market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions
24. Mukesh is an engineering graduate with
an MBA in Marketing. He is a seasoned
healthcare market research & marketing
professional with a progressive
experience of over 20 years in Life
Sciences, Pharma and Medical Device
sectors . With an in-depth understanding
of primary research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare &
completed several research projects
across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across diff.
markets (America, Europe, Africa, APAC
and Middle East). Her areas of expertise
include: Identifying emerging trends in life
sciences industry, Competitor landscape
assessment, Disease opportunity
assessments etc. She is a pro in secondary
and primary research with a deep domain
expertise in healthcare sector.
Purav is a physician and an entrepreneur
with 12+ years of experience in Healthcare
& Life Sciences industry spanning across
strategy, market access, health informatics
and RWE, Digital Healthcare, analytics and
data science. Purav studied medicine from
Gujarat University and also completed his
MBA from IIM-Kozhikode. Purav started his
career with Deloitte working on strategy
consulting engagements and also
co-founded ConvergeHealth by Deloitte.
Dhruv Joshi is an engineer and has done
Masters in Hospital Administration with over
4 years of experience in the healthcare and
life science industry. He has gained
proficiency in market research, market
assessment, and developing insights from it.
He has worked on various consulting
projects across different geographies
including Asia, Europe, US, MENA. He has
been aligned in working for sector reports of
various geographies along with market
sizing and forecasting.
Dr. Purav Gandhi
Founder & CEO
Mukesh Nayak
Head - Marketing
Ritu Baliya
Engagement Manager
Dhruv Joshi
Consultant
Project Leadership Team
25. 7 years of experience working with leading organizations in pharma, MedTech
and healthcare domain. Some of our recent clients are mentioned below
… and many more